Pfizer to Make $54 Billion Off Treating COVID Over and Over – Analysis by Dr. Joseph Mercola
The pandemic has been disastrous, to say nothing of deadly, for the vast majority of us, but that doesn’t mean COVID-19 hasn’t represented a boon for certain sectors. Case in point: Pfizer, which is on pace to see more than $100 billion in additional revenue thanks to the COVID vaccine and Paxlovid, which together have more than doubled Pfizer’s sales figures since early 2020. And with no end to COVID-19 in sight, Pfizer is poised to keep on raking in the billions for treating, but never eradicating, what has turned out to be a very profitable virus for this Big Pharma enterprise.
Jimmy and America’s comedian Kurt Metzger discuss the windfall Pfizer has enjoyed thanks to this oft-mutating bugger of a virus.